(Q43515313)

24 November 2017

Antenatal betamethasone treatment reduces synaptophysin immunoreactivity in presynaptic terminals in the fetal sheep brain (English)

1 reference

24 November 2017

1 reference

6

1 reference

24 November 2017

Antonow-Schlorke I

1

1 reference

24 November 2017

Kühn B

2

1 reference

24 November 2017

Müller T

3

1 reference

24 November 2017

Schubert H

4

1 reference

24 November 2017

Sliwka U

5

1 reference

24 November 2017

Schwab M

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

24 November 2017

1 reference

24 November 2017

297

1 reference

24 November 2017

3

1 reference

24 November 2017

147-150

1 reference

Charting of Type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Stress, glucocorticoids and development.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

A lectin and synaptophysin study of developing brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

DNA, ganglioside and sulfatide in brains of rats given corticosterone in infancy, with an estimate of cell loss during development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Synaptophysin expression during synaptogenesis in the rat cerebellar cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

MAP2, synaptophysin immunostaining in rat brain and behavioral modifications after cerebral postischemic reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Synaptic and neuritic alterations during the progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Quantitative synaptic alterations in the human neocortex during normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Steroid hormone actions on the brain: when is the genome involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901605-0

7 January 2021

10.1016/S0304-3940(00)01605-0

Identifiers

DOI

1 reference

24 November 2017

1 reference